STANLEY NWABUDIKE

Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology ALBUQUERQUE, NM NPI 1851700751

General Payments — all program years on this page

$791.95

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 31
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $400.11 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $365.2314
Education $34.881

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2019 $99.991
2022 $33.212
2023 $258.6413
2024 $400.1115

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078383798 Janssen Biotech, Inc. $36.83 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087136618 Novartis Pharmaceuticals Corporation $21.41 01/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087136620 Novartis Pharmaceuticals Corporation $22.23 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087136624 Novartis Pharmaceuticals Corporation $26.91 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087136626 Novartis Pharmaceuticals Corporation $28.64 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087136628 Novartis Pharmaceuticals Corporation $20.16 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089463592 Daiichi Sankyo Inc. $21.57 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101155336 Celgene Corporation $29.93 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110782358 Eisai Inc. $22.88 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117643503 Amgen Inc. $29.20 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1128610349 Kite Pharma, Inc. $23.95 08/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131385988 ARRAY BIOPHARMA INC $22.49 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137942358 TAIHO ONCOLOGY, INC. $17.36 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144964260 Takeda Pharmaceuticals U.S.A., Inc. $34.88 05/10/2024 Education Undisputed 01/23/2026 View at CMS
1144964262 Takeda Pharmaceuticals U.S.A., Inc. $41.67 06/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.